About Ce-Chem Pharmaceuticals Private Limited
Data last updated:
Ce-Chem Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85310KA1992PTC013586. Its GSTIN is 29AAACI3514N1ZE (Karnataka).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.7 Cr. It was formerly known as Integrated Health and Allied Services Private Limited. It is led by directors including Chandrashekar Mithoor (Managing Director) and Chandramathi Gopalkrishna Rao (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.336 IV Phase 9th Cross Peenya Industrial Area, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.36 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹69.69 Lakh (net margin 3.3%) and EBITDA of ₹1.75 Cr (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 66 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Purayati and Ce-Chem. As per MCA filings, the company has open charges of ₹8.83 Cr and satisfied charges of ₹5.4 Lakh on record. Court records list 10 cases involving the company, including 3 filed by the company and 7 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ce-chem.com.
Company details
Contact details
Ce-Chem Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is ce-chem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.336 IV Phase 9th Cross Peenya Industrial Area, Bangalore, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ce-Chem Pharmaceuticals operates two associated brands: Purayati and Ce-Chem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers vitamins, minerals, and health supplements online for consumers. | purayati.com | |
| Manufacturing and supply of medicines and supplements in the healthcare sector. | ce-chem.com |
Business activity
The main business activities of Ce-Chem Pharmaceuticals are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Financials of Ce-Chem Pharmaceuticals Private Limited
FY 2025 filings availableCe-Chem Pharmaceuticals Private Limited reported revenue of ₹21.36 Cr (up 53% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 53% growth in the latest year. EBITDA rose 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ce-Chem Pharmaceuticals Private Limited
Ce-Chem Pharmaceuticals has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandramathi Gopalkrishna Rao | Whole-Time Director | 30 Sep 1992 | 34 Years 1 Months | Current |
| Tejasvi Bhat | Whole-Time Director | 08 Jan 2008 | 18 Years 9 Months | Current |
| Chandrashekar Mithoor | Managing Director | 08 Jan 2008 | 18 Years 9 Months | Current |
| Sarojini Mithoor | Director | 08 Jan 2008 | 18 Years 9 Months | Current |
Peer comparison
Ce-Chem Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunrise International Labs Limited | ₹21.39 Cr (FY 2024) | 6.0% | Hyderabad, Telangana, India | |||
| Ce-Chem Pharmaceuticals Private Limitedthis company | ₹21.36 Cr (FY 2025) | ₹69.69 Lakh | 3.3% | 53.0% | 66 | Bangalore, Karnataka, India |
| Nagarjun Pharmaceuticals Pvt Ltd | ₹21.3 Cr (FY 2024) | 6.0% | Gandhinagar, Gujarat, India | |||
| Dexbio Pharma Private Limited | ₹21.29 Cr (FY 2025) | 17.0% | Roorkee, Uttarakhand, India | |||
| Dios Lifesciences Private Limited | ₹21.24 Cr (FY 2024) | 44.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Auditor
Ce-Chem Pharmaceuticals Private Limited is audited by P GANAPATHI BHAT AND CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P GANAPATHI BHAT AND CO | FY 2024 | 0000847S |
Shareholding
The shareholding of Ce-Chem Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Nov 2024 | 101007964 | Karnataka State Financial Corporation | ₹1.62 Cr | Open | |
| 31 Jul 2024 | 100955015 | Sidbi | ₹4.54 Cr | Open | |
| 31 Oct 2022 | 100642487 | Others | ₹20 Lakh | Open | |
| 29 Nov 2008 | 10132366 | State Bank of India | ₹2.47 Cr | Open | |
| 23 May 2016 | 100035082 | State Bank of India | ₹5.4 Lakh | Satisfied |
To see the full charge records of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Ce-Chem Pharmaceuticals Private Limited has 10 court cases on record: 3 filed by Ce-Chem Pharmaceuticals, 7 filed against it. 1 case is pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 3 | 0 |
| District courts | 3 | 3 | 1 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed by the company against North Karnataka Durgs and Pharmaceutical Manufacturers Welfare Association Represented by Its Hon.Secretary C/O Nandu Chemicals Pvt.Ltd., N-12, Industrial Estate Gokul Road Hubli-580 030 , , Karnataka and 19 others | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Onkareshwara B.B. Assistant Drugs Controller-1, Bengaluru-2. | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Union of India Secretary Department of Health, A Wing, Nirman Bhavan, , District: New Delhi , , Delhi and 15 others | Disposed |
To see the full case history of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ce-Chem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ce-Chem Pharmaceuticals Private Limited has a workforce of 66 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
GST
Ce-Chem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACI3514N1ZE | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ce-Chem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ce-Chem Pharmaceuticals Private Limited has 9 board changes on record since 1992: 4 appointments and 5 cessations. The latest: Chandramathi Gopalkrishna Rao ceased to be Managing Director on 01 Jul 2008.
7 earlier events are in the company report.
Frequently asked questions
Ce-Chem Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1992 (34+ years old) and is registered under CIN U85310KA1992PTC013586.
Ce-Chem Pharmaceuticals has 4 current directors:
- Chandrashekar Mithoor - Managing Director
- Chandramathi Gopalkrishna Rao - Whole-Time Director
- Tejasvi Bhat - Whole-Time Director
- Sarojini Mithoor - Director
The latest financial statements of Ce-Chem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ce-Chem Pharmaceuticals is 29AAACI3514N1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Ce-Chem Pharmaceuticals is U85310KA1992PTC013586. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ce-Chem Pharmaceuticals has 10 court cases on record: 3 filed by the company and 7 filed against it. 1 is pending. Most are in the high courts.
Ce-Chem Pharmaceuticals was incorporated on 30 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Ce-Chem Pharmaceuticals by revenue are Sunrise International Labs Limited, Nagarjun Pharmaceuticals Pvt Ltd, Dexbio Pharma Private Limited, Dios Lifesciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandramathi Gopalkrishna Rao ceased to be Managing Director on 01 Jul 2008. Chandrashekar Mithoor ceased to be Additional Director on 30 Jun 2008. Sarojini Mithoor ceased to be Additional Director on 30 Jun 2008. Ce-Chem Pharmaceuticals has 9 board changes on record in total.
Ce-Chem Pharmaceuticals can be reached through the website ce-chem.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Ce-Chem Pharmaceuticals is at No.336 IV Phase 9th Cross Peenya Industrial Area, Bangalore, Karnataka, India – 560058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
